LONDON--Research-based pharmaceutical and healthcare company GlaxoSmithKline PLC (GSKl.LN) said Monday that the initial tender offer for Human Genome Sciences Inc (HGSI) expired 0400 GMT on July 26, and at that time 158.61 million shares, or 79%, had been validly tendered and not withdrawn.

MAIN FACTS:

-An additional 9.16 million Human Genome shares, or 4%, were tendered subject to guaranteed delivery procedures.

-GlaxoSmithKline shares at 1235 GMT up 17 pence, or 1.14%, at 1460 pence valuing the company at 72.03 billion pounds.

-Write to Ian Walker at ian.walker@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Grafico Azioni Human Genome Sciences (NASDAQ:HGSI)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Human Genome Sciences
Grafico Azioni Human Genome Sciences (NASDAQ:HGSI)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Human Genome Sciences